SCHEMBL1546460

SCHEMBL1546460

FCCc1[c]ccc(-c2ncc[nH]2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 2/20 0.41
MTOR P42345 1/20 0.41
ADK P55263 1/20 0.41
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
SMPD3 Q9NY59 1/20 0.34
MRGPRX4 Q96LA9 1/20 0.33
KCNH2 Q12809 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
BRD4 O60885 1/20 0.32
ADRA2A P08913 3/20 0.31
ADRA2B P18089 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1545961 0.85 CYP1A2 (0.46) NISCHMTORADKCYP1A2CYP3A4
SCHEMBL1545894 0.82 NISCH (0.45) NISCHMTORADKCYP1A2CYP3A4
SCHEMBL1723783 0.78 NISCH (0.40) NISCHMTORADKCYP1A2CYP3A4
SCHEMBL1545797 0.77 VCP (0.40) NISCHMTORADKCYP1A2CYP3A4
SCHEMBL11647219 0.73 NISCH (0.47) NISCHMTORADKCYP1A2CYP3A4
SCHEMBL1545794 0.73 NISCH (0.53) NISCHMTORADKCYP1A2CYP3A4
SCHEMBL1546458 0.71 NISCH (0.42) NISCHMTORADKCYP1A2CYP3A4
SCHEMBL208465 0.68 NISCH (0.63) NISCHMTORADKCYP1A2CYP3A4
SCHEMBL8797054 0.67 NISCH (0.61) NISCHMTORADKCYP1A2CYP3A4
SCHEMBL16777437 0.66 NISCH (0.72) NISCHMTORADKCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809597-B1 AMINOETHYLAROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO KG (DE) 2012-01-11 EP disclosed
EP-2311801-A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor Abbott GmbH & Co. KG (DE) 2011-04-20 EP disclosed
EP-2311803-A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Abbott GmbH & Co. KG (DE) 2011-04-20 EP disclosed